<DOC>
	<DOC>NCT00643799</DOC>
	<brief_summary>To compare the safety and efficacy of celecoxib versus naproxen for the treatment of knee osteoarthritis</brief_summary>
	<brief_title>Safety and Efficacy of Celecoxib Versus Naproxen in the 6-Month Treatment of Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Osteoarthritis of the knee as defined by the American College of Rheumatology criteria in a flare state at baseline visit Functional Capacity Classification of IIII Inflammatory arthritis or gout/pseudogout with an acute flare within the past 2 years (subjects with fibrositis or fibromyalgia will not be excluded) Received acetaminophen within 24 hours of the baseline visit Acute joint trauma at index joint within the past 3 months with active symptoms History of gastrointestinal (GI) perforation, obstruction, or bleeding Diagnosed or treated for GI ulcer within 60 days prior to first dose of study medication Received corticosteroids or hyaluronic acid within certain timeframe before study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>